Skip to main content
Fig. 1 | Trials

Fig. 1

From: Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial

Fig. 1

Simplified illustration of possible mechanisms after Neu2000 administration to mitigate reperfusion injury in the setting of recanalization treatment. a Ischemic cascade after stroke and proposed effect of multi-target neuroprotection. b The expected effect of reperfusion with multi-target neuroprotection on burden of cell damage and functional outcome

Back to article page

Trials

ISSN: 1745-6215